PLoS ONE (Jan 2012)

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

  • Michael G Schrauder,
  • Reiner Strick,
  • Rüdiger Schulz-Wendtland,
  • Pamela L Strissel,
  • Laura Kahmann,
  • Christian R Loehberg,
  • Michael P Lux,
  • Sebastian M Jud,
  • Arndt Hartmann,
  • Alexander Hein,
  • Christian M Bayer,
  • Mayada R Bani,
  • Swetlana Richter,
  • Boris R Adamietz,
  • Evelyn Wenkel,
  • Claudia Rauh,
  • Matthias W Beckmann,
  • Peter A Fasching

DOI
https://doi.org/10.1371/journal.pone.0029770
Journal volume & issue
Vol. 7, no. 1
p. e29770

Abstract

Read online

IntroductionMicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules with relevance as regulators of gene expression thereby affecting crucial processes in cancer development. MiRNAs offer great potential as biomarkers for cancer detection due to their remarkable stability in blood and their characteristic expression in many different diseases. We investigated whether microarray-based miRNA profiling on whole blood could discriminate between early stage breast cancer patients and healthy controls.MethodsWe performed microarray-based miRNA profiling on whole blood of 48 early stage breast cancer patients at diagnosis along with 57 healthy individuals as controls. This was followed by a real-time semi-quantitative Polymerase Chain Reaction (RT-qPCR) validation in a separate cohort of 24 early stage breast cancer patients from a breast cancer screening unit and 24 age matched controls using two differentially expressed miRNAs (miR-202, miR-718).ResultsUsing the significance level of pConclusionsMiRNA profiling in whole blood has potential as a novel method for early stage breast cancer detection, but there are still challenges that need to be addressed to establish these new biomarkers in clinical use.